RPTOR and malignant colon neoplasm: Consistent with TCGA data, RAPTOR was highly expressed in 76.24% (77/101) colon cancer specimens, whereas its high expression was detected only in 48.51% (49/101) of paired adjacent normal samples (P < .0001; Figure 1D,E).